GADD34 suppresses eIF2α phosphorylation and improves cognitive function in Alzheimer's disease-model mice
GADD34 suppresses eIF2α phosphorylation and improves cognitive function in Alzheimer's disease-model mice
复制标题
GADD34 抑制 eIF2α 磷酸化并改善阿尔茨海默病模型小鼠的认知功能
DOI:
10.1016/j.bbrc.2023.02.077
复制
发表时间:
2023
影响因子:
3.1
通讯作者:
Masanori Itoh
中科院分区:
文献类型:
--
作者:
Miki Hayakawa-Ogura;Tana;Toshiyuki Nakagawa;Masanori Itoh
Alzheimer's disease (AD) causes neurodegeneration, leading to cognitive impairment and memory loss. Our previous studies have demonstrated that the induction of growth arrest and DNA damage-inducible gene 34 (GADD34) by quercetin can affect eukaryotic translation initiation factor 2α (eIF2α) phosphorylation-activated transcription factor 4 (ATF4) signaling. However, the relationship between GADD34 expression and cognitive function has not been clarified. In this study, we determined the direct effect of GADD34 on memory. To achieve this, truncatedGADD34(GADD34.5) was injected into the mouse brain to suppress eIF2α phosphorylation and evaluate memory. The injection ofGADD34.5into the hippocampus in AD-model mice did not improve novel object recognition but improved novel object location. The injection ofGADD34.5into the amygdala also resulted in the maintenance of contextual fear memory based on the fear condition test. These results suggest that GADD34 is effective in improving memory for spatial cognition and contextual fear conditioning in AD by inhibiting eIF2α phosphorylation. In summary, GADD34 suppresses eIF2α phosphorylation in the brain and prevents memory loss. As quercetin feeding increases GADD34 expression, it might be used in preventative applications for AD.